- All sections
- C - Chemistry; metallurgy
- C07K - Peptides
- C07K 1/107 - General processes for the preparation of peptides by chemical modification of precursor peptides
Patent holdings for IPC class C07K 1/107
Total number of patents in this class: 1142
10-year publication summary
|
78
|
75
|
73
|
84
|
77
|
99
|
84
|
96
|
119
|
4
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 19517 |
27 |
| Forschungsverbund Berlin e.V. | 195 |
16 |
| Janssen Pharmaceutica N.V. | 3612 |
14 |
| Ludwig-Maximilians-Universitat Munchen | 341 |
14 |
| Bristol-myers Squibb Company | 4863 |
13 |
| President and Fellows of Harvard College | 5913 |
13 |
| Quiapeg Pharmaceuticals AB | 47 |
13 |
| Massachusetts Institute of Technology | 9913 |
12 |
| Pfizer Inc. | 3368 |
11 |
| Takeda Pharmaceutical Company Limited | 2943 |
11 |
| NBE Therapeutics AG | 39 |
9 |
| Bicyclerd Limited | 138 |
9 |
| Novo Nordisk A/S | 2278 |
9 |
| F. Hoffmann-La Roche AG | 7942 |
8 |
| New York University | 1686 |
8 |
| Roche Sequencing Solutions, Inc. | 613 |
8 |
| Aileron Therapeutics, Inc. | 83 |
7 |
| Hybio Pharmaceutical Co., Ltd. | 120 |
7 |
| Jiangsu Hengrui Medicine Co., Ltd. | 760 |
7 |
| Universiteit Gent | 1321 |
7 |
| Other owners | 919 |